dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada SGLT-2 inhibitors, agonists, inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study Differences between GLP-1 receptor agonists
Description
JAMA Intern Med 2016;176:1464-73.ArticlePubMed 30
Acute exenatide (Byetta) poisoning was not associated with significant hypoglycemia
Why weight comes back Weight regain is not a willpower failure
Summer bods are the summer fashion
1.7% vs 1.0%point), respectively
Others may argue that for people who have a large percentage of weight to lose and struggle getting started with a more foundational approach to weight loss, drugs like Wegovy can give them a jump start or help get their foot in the door on healthier habits by helping them control their appetite in the beginning
